STAFF BOARD

CHAIRMAN
Maruxa Hernández Corredoira
EDITOR IN CHIEF
Manuela Velázquez Prieto
Tomás Casasín Edo
MARKETING MANAGER
EDITORIAL BOARD
María B. Badía Tahull
Lluís Campins Bernadas
Juan Carlos Juárez Giménez
Carles Quiñones Ribas

Smart Pill Boxes versus Pharmacist-Filled Organizers in Uncontrolled Hypertension

Torres Gabriela Alejandra1
1Hospital Clínico Universidad de Chile
Corresponding Email: tgabriela.alejandra@gmail.com

Background: Weekly pharmacist-filled pill boxes improve medication organization, yet effects on blood pressure (BP) are inconsistent and short-lived when adherence is measured indirectly. Connected pill organizers that log dose-time events and deliver automated reminders enable objective adherence feedback and may enhance BP control at scale.
Objective: To determine whether a connected smart pill-box service reduces 24-h ambulatory blood pressure monitoring (ABPM) systolic BP (SBP) at 6 months compared with a pharmacist-filled weekly pill-box service among adults with uncontrolled hypertension.
Design: Multisite, parallel-group randomized controlled trial (1:1) with 6-month primary endpoint and 12-month maintenance follow-up.
Participants: Adults with uncontrolled hypertension on  ≥ 2 antihypertensives from primary care or veteran clinics; inclusive of caregiver-supported medication management and diverse literacy levels.
Interventions: Smart arm: connected organizer with dose-time logging, app/SMS nudges, and monthly pharmacist feedback based on device data. Control arm: pharmacist-filled weekly pill boxes (enhanced usual care). Protocolized medication titration allowed in both arms.
Primary Outcome: Change in 24-h ambulatory blood pressure monitoring (ABPM) SBP from baseline to 6 months.
Key Secondary Outcomes: Time-in-target SBP, automated office BP, electronic adherence (% on-time doses), medication changes, serious adverse events (syncope, AKI, hyperkalemia), ED/inpatient utilization, usability/acceptability, and cost per controlled patient.
Sample Size: Detecting a between-group difference of 4mmHg (SD 12mmHg), two-sided α = 0.05, 80–90% power requires 142–189 per arm; inflated by 15% for attrition.
Conclusions: SMART-BOX tests an objective-adherence, scalable strategy with 24-h ambulatory blood pressure monitoring (ABPM) endpoints and concurrent economic evaluation to inform routine hypertension care.

Keywords: Hypertension; Medication Adherence; Digital Health; Ambulatory Blood Pressure Monitoring; Randomized Controlled Trial; Cost-Effectiveness